Ketoacidosis in type 2 diabetics on SGLT-2 inhibitors

Ketoacidosis in type 2 diabetics on SGLT-2 inhibitors: a prospective observational cohort study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN96827601

Enrollment

Registered

2016-09-12

Start date

2016-11-01

Completion date

Unknown

Last updated

2016-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus Nutritional, Metabolic, Endocrine Type 2 diabetes mellitus

Interventions

Potential participants for this study have already been on SGLT2i treatment for a time prior to enrollment and are identified when they attend their usual primary care or secondary care appointment as

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with type 2 diabetes taking SGLT2i 2. Age > 18 3. Able to give consent

Exclusion criteria

Exclusion criteria: Participants that do not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
Number of episodes of ketoacidosis, from blood analyses using samples taken via a pin prick test or blood test. Measured at baseline and when the participant is feeling unwell during the study period.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026